Literature DB >> 23542754

Automated Neuropsychological Test Battery in depression -- preliminary data.

Anikó Egerházi1, Petra Balla, Andrea Ritzl, Zsófia Varga, Ede Frecska, Roland Berecz.   

Abstract

AIMS: Studies have demonstrated neuropsychological deficits across a variety of cognitive domains in patients with major depressive disorder (MDD) during acute episode. However, limited data are available concerning whether these abnormalities persist in the remission phase.
METHODS: In the present study CANTAB (Cambridge Automated Neuropsychological Test Battery) was used to evaluate the cognitive impairment associated with depression during acute episode and in remission. 25 patients with MDD during an acute episode and 11 patients also during remission were tested with CANTAB.
RESULTS: During the acute episode, Delayed matching to sample, Paired associate learning, Spatial recognition memory, Rapid visual processing and Visuospatial planning were impaired. In remission the improvement of visual learning ability, spatial recognition memory, psychomotor speed, and executive function was observed.
CONCLUSIONS: The results suggest that MDD is associated with neurocognitive dysfunctions in different domains, the most prominent deficit was found in the Paired associate learning test, which requires both the elaboration of "frontal strategies" and the "mnemonic processes". Cognitive impairment was found to improve partly in remission, suggesting that an individual's current mood interacts with the ability to perform a cognitive task. Besides these state markers, trait deficits are important because cognitive impairments which do not improve in remission might serve as endophenotypes of depression.

Entities:  

Mesh:

Year:  2013        PMID: 23542754

Source DB:  PubMed          Journal:  Neuropsychopharmacol Hung        ISSN: 1419-8711


  7 in total

1.  Differences in the cognitive profile of depression between racial groups.

Authors:  Jon E Grant; Michael Harries; Samuel R Chamberlain
Journal:  Ann Clin Psychiatry       Date:  2018-02       Impact factor: 1.567

2.  Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment.

Authors:  Olivia Bauer; Vladimir M Milenkovic; Sven Hilbert; Nina Sarubin; Johannes Weigl; Lisa-Marie Bahr; Thomas C Wetter; Barbara Heckel; Christian H Wetzel; Rainer Rupprecht; Caroline Nothdurfter
Journal:  Neuroimmunomodulation       Date:  2021-01-27       Impact factor: 2.492

Review 3.  Pseudo-dementia: A neuropsychological review.

Authors:  Hai Kang; Fengqing Zhao; Llbo You; Cinzia Giorgetta; Venkatesh D; Sujit Sarkhel; Ravi Prakash
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

4.  Behavioural and Psychological Symptoms in Neurocognitive Disorders: Specific Patterns in Dementia Subtypes.

Authors:  Réka Majer; Viktória Simon; László Csiba; László Kardos; Ede Frecska; Tibor Hortobágyi
Journal:  Open Med (Wars)       Date:  2019-04-04

5.  Association between polymorphism of the NEDD4 gene and cognitive dysfunction of schizophrenia patients in Chinese Han population.

Authors:  Chao Han; Kaiyan Cui; Xiaojiao Bi; Lina Wang; Mengmeng Sun; Limin Yang; Lanfen Liu
Journal:  BMC Psychiatry       Date:  2019-12-18       Impact factor: 3.630

Review 6.  Cognitive Impairment and Neurocognitive Profiles in Major Depression-A Clinical Perspective.

Authors:  Åsa Hammar; Eivind Haga Ronold; Guro Årdal Rekkedal
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

7.  Learning and memory impairments in a neuroendocrine mouse model of anxiety/depression.

Authors:  Flavie Darcet; Indira Mendez-David; Laurent Tritschler; Alain M Gardier; Jean-Philippe Guilloux; Denis J David
Journal:  Front Behav Neurosci       Date:  2014-05-01       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.